R Rossetto

Author PubWeight™ 17.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Int J Obes Relat Metab Disord 1999 1.11
2 Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. J Clin Endocrinol Metab 2000 0.97
3 Adrenal responsiveness to high, low and very low ACTH 1-24 doses in obesity. Clin Endocrinol (Oxf) 2000 0.92
4 Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. J Clin Endocrinol Metab 2003 0.88
5 Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol (Oxf) 2004 0.88
6 Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome. J Clin Endocrinol Metab 2002 0.87
7 Thyroid volume and urinary iodine excretion in the schoolchild population of a Northwestern Italian sub-Alp metropolitan area. J Endocrinol Invest 2004 0.84
8 Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity. J Endocrinol Invest 1999 0.83
9 Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. Int J Obes Relat Metab Disord 2001 0.83
10 Influence of vitrification techniques and solutions on the morphology and survival of preantral follicles after in vitro culture of caprine ovarian tissue. Theriogenology 2011 0.82
11 Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test. J Endocrinol Invest 1999 0.82
12 Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women. Clin Endocrinol (Oxf) 1999 0.82
13 The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors. Int J Obes Relat Metab Disord 2000 0.80
14 Goiter prevalence and urinary iodine status in urban and rural/mountain areas of Piedmont region. J Endocrinol Invest 2006 0.79
15 Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension. J Endocrinol Invest 1998 0.79
16 Dynamic medium produces caprine embryo from preantral follicles grown in vitro. Reprod Sci 2010 0.79
17 Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity. Ann Endocrinol (Paris) 2002 0.78
18 Interaction between estradiol and follicle-stimulating hormone promotes in vitro survival and development of caprine preantral follicles. Cells Tissues Organs 2009 0.78
19 Interaction between growth differentiation factor 9, insulin-like growth factor I and growth hormone on the in vitro development and survival of goat preantral follicles. Braz J Med Biol Res 2010 0.77
20 Steady-state level of bone morphogenetic protein-15 in goat ovaries and its influence on in vitro development and survival of preantral follicles. Mol Cell Endocrinol 2011 0.77
21 Glucagon administration elicits blunted GH but exaggerated ACTH response in obesity. J Endocrinol Invest 2002 0.76
22 A simple model to assess nitrogen and phosphorus contamination in ungauged surface drainage networks: application to the Massaciuccoli Lake Catchment, Italy. J Environ Qual 2012 0.75
23 Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patients. J Endocrinol Invest 1997 0.75
24 Dynamic medium containing kit ligand and follicle-stimulating hormone promotes follicular survival, activation, and growth during long-term in vitro culture of caprine preantral follicles. Cells Tissues Organs 2011 0.75
25 Alginate hydrogel matrix stiffness influences the in vitro development of caprine preantral follicles. Mol Reprod Dev 2014 0.75
26 [Multiple endocrine neoplasia type 2. Biological and clinical aspects]. Minerva Chir 2004 0.75
27 Age-related endocrine and metabolic changes in simple obesity. J Endocrinol Invest 2002 0.75
28 The effects of epidermal growth factor (EGF) on the in vitro development of isolated goat secondary follicles and the relative mRNA expression of EGF, EGF-R, FSH-R and P450 aromatase in cultured follicles. Res Vet Sci 2012 0.75
29 Expression of keratinocyte growth factor in goat ovaries and its effects on preantral follicles within cultured ovarian cortex. Reprod Sci 2011 0.75
30 [Treatment of familial medullary thyroid carcinoma]. Minerva Chir 2003 0.75
31 GH/IGF-I axis in azoospermia in primary and secondary hypogonadism: a study before and during replacement therapy. Int J Androl 1999 0.75
32 Adrenal sensitivity to ACTH1-24 as function of age, body weight and pituitary function. J Endocrinol Invest 2002 0.75
33 Moment of addition of LH to the culture medium improves in vitro survival and development of secondary goat pre-antral follicles. Reprod Domest Anim 2010 0.75